Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes

Intrahepatic cholestasis of pregnancy (ICP) increases adverse perinatal outcome (APO) incidence. Whether successful treatment of severe ICP reduces APO risk is unclear. This retrospective, single-center study in China enrolled consecutive women with ICP who had term delivery (≥37 weeks, singleton) b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jielian, Chen, Chong, Liu, Min, Zhang, Shuye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635289/
https://www.ncbi.nlm.nih.gov/pubmed/31277130
http://dx.doi.org/10.1097/MD.0000000000016214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635289/
https://www.ncbi.nlm.nih.gov/pubmed/31277130
http://dx.doi.org/10.1097/MD.0000000000016214

Ejemplares similares